Market revenue in 2022 | USD 227.0 million |
Market revenue in 2030 | USD 476.4 million |
Growth rate | 9.7% (CAGR from 2022 to 2030) |
Largest segment | Transmitter & receiver |
Fastest growing segment | Insulin Pumps |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Sensors, Transmitter & Receiver, Insulin Pumps |
Key market players worldwide | DexCom Inc, Abbott Laboratories, Medtronic PLC, Ypsomed Holding AG, Senseonics Holdings Inc, A.Menarini Diagnostics, Signos |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to continuous glucose monitoring devices market will help companies and investors design strategic landscapes.
Transmitter & receiver was the largest segment with a revenue share of 36.56% in 2022. Horizon Databook has segmented the China continuous glucose monitoring devices market based on sensors, transmitter & receiver, insulin pumps covering the revenue growth of each sub-segment from 2018 to 2030.
It is estimated that approximately one in ten individuals in China have diabetes, making it difficult to determine the exact number of cases due to several going undetected. China has now become the country with the highest diabetic population in the world, surpassing India. Diabetes is most prevalent due to urbanization, improved standards of living, and an aging population.
To reduce medical expenses for diabetic and high blood pressure patients, the National Health Commission of China has started reimbursing outpatients for over half of their medication costs. In addition, more hospitals in China are planning to establish National Metabolic Management Centers (MMC) to explore a new model of diabetes treatment.
These MMCs have already provided services to over 200,000 patients in the last 2 years, as reported by China’s National Health Commission statistics. Companies interested in entering China should recognize that they must overcome existing barriers in an ambiguous and changing regulatory environment.
Horizon Databook provides a detailed overview of country-level data and insights on the China continuous glucose monitoring devices market , including forecasts for subscribers. This country databook contains high-level insights into China continuous glucose monitoring devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account